Paper31301289
Application of "macromolecular crowding" in vitro to investigate the naphthoquinones shikonin, naphthazarin and related analogues for the treatment of dermal scars.
Fan C and 5 others. Chem Biol Interact, 2019. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Application of "macromolecular crowding" in vitro to investigate the naphthoquinones shikonin, naphthazarin and related analogues for the treatment of dermal scars. Papers, record 31301289. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31301289
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Application of "macromolecular crowding" in vitro to investigate the naphthoquinones shikonin, naphthazarin and related analogues for the treatment of dermal scars.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cicatrix | Major topic |
| Naphthoquinones | Major topic |
| Animals | |
| Apoptosis | |
| Cell Line | |
| Cicatrix, Hypertrophic | |
| Collagen | |
| Extracellular Matrix | |
| Fibroblasts | |
| Humans | |
| Models, Biological | |
| Skin |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942802 | Development and Characterization of Shikonin-Loaded NLC with Enhanced Photostability in Hydrogel-Based Dermal Patch. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942802 | PubMed |
| 42564135 | Pyruvate kinase M2 is elevated in systemic sclerosis and plays a role in its pathogenesis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42564135 | PubMed |
| 42058963 | High-yield cell-derived extracellular matrix bioink via macromolecular crowding for versatile 3D bioprinting. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42058963 | PubMed |
| 41095128 | Innovative Hydroponic Culture of Alkanna tinctoria (L.) Tausch: An Approach Towards Sustainable Extraction Process from Plant Roots. | Plants (Basel) | 2025 | https://conductscience.org/library/papers/41095128 | PubMed |
| 41004011 | Macromolecular Crowding for Reparative Medicine and Drug Discovery Applications. | Subcell Biochem | 2025 | https://conductscience.org/library/papers/41004011 | PubMed |
| 40880647 | Research progress of dissolving microneedles in the field of component administration of traditional Chinese medicine. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40880647 | PubMed |
| 40732110 | An UHPLC-HRMS-Based Untargeted Metabolomics Approach to Explore the Effects of Bacterial Endophyte Co-Culture on Alkanna tinctoria (L.) Tausch Cell Suspension Metabolome. | Microorganisms | 2025 | https://conductscience.org/library/papers/40732110 | PubMed |
| 40331149 | Underestimated role of macromolecular crowding in bioengineered in vitro models of health and diseases. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40331149 | PubMed |
| 39296083 | Natural products for the treatment of hypertrophic scars: Preclinical and clinical studies. | Heliyon | 2024 | https://conductscience.org/library/papers/39296083 | PubMed |
| 38886773 | Insights into the role of mesenchymal stem cells in cutaneous medical aesthetics: from basics to clinics. | Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/38886773 | PubMed |
| 38138440 | Pharmacological Effects of Shikonin and Its Potential in Skin Repair: A Review. | Molecules | 2023 | https://conductscience.org/library/papers/38138440 | PubMed |
| 36739306 | Macromolecular crowding regulates matrix composition and gene expression in human gingival fibroblast cultures. | Sci Rep | 2023 | https://conductscience.org/library/papers/36739306 | PubMed |
| 36405061 | Pharmacological and analytical aspects of alkannin/shikonin and their derivatives: An update from 2008 to 2022. | Chin Herb Med | 2022 | https://conductscience.org/library/papers/36405061 | PubMed |
| 35847041 | Review of Shikonin and Derivatives: Isolation, Chemistry, Biosynthesis, Pharmacology and Toxicology. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35847041 | PubMed |
| 34765594 | Adapting the Scar-in-a-Jar to Skin Fibrosis and Screening Traditional and Contemporary Anti-Fibrotic Therapies. | Front Bioeng Biotechnol | 2021 | https://conductscience.org/library/papers/34765594 | PubMed |
| 33852183 | Engineering Advanced In Vitro Models of Systemic Sclerosis for Drug Discovery and Development. | Adv Biol (Weinh) | 2021 | https://conductscience.org/library/papers/33852183 | PubMed |
| 33057073 | Dermal fibroblasts have different extracellular matrix profiles induced by TGF-β, PDGF and IL-6 in a model for skin fibrosis. | Sci Rep | 2020 | https://conductscience.org/library/papers/33057073 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31301289
GET https://conductscience.org/api/papers/v1/31301289/authors